Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes von Bebernitz, Gregory R, Beaulieu, Valerie, Dale, Bethany A, Deacon, Richard, Duttaroy, Alokesh, Gao, Jiaping, Grondine, Melissa S, Gupta, Ramesh C, Kakmak, Mesut, Kavana, Michael, Kirman, Louise C, Liang, Jinsheng, Maniara, Wieslawa M, Munshi, Siralee, Nadkarni, Sunil S, Schuster, Herbert F, Stams, Travis, St. Denny, Irene, Taslimi, Paul M, Vash, Brian, Caplan, Shari L

Volltext

Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study von SCHUSTER, Herbert, BARTER, Philip J, STENDER, Steen, CHEUNG, Raphael C, BONNET, Jacques, MORRELL, Jonathan M, WATKINS, Claire, KALLEND, David, RAZA, Ali

Volltext

Avoidance of the Ames test liability for aryl–amines via computation von McCarren, Patrick, Bebernitz, Gregory R., Gedeck, Peter, Glowienke, Susanne, Grondine, Melissa S., Kirman, Louise C., Klickstein, Jacob, Schuster, Herbert F., Whitehead, Lewis

Volltext

The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice von Bebernitz, Gregory R, Argentieri, Greg, Battle, Beverly, Brennan, Christine, Balkan, Bork, Burkey, Bryan F, Eckhardt, Michele, Gao, Jiaping, Kapa, Prasad, Strohschein, Robert J, Schuster, Herbert F, Wilson, Mary, Xu, David D

Volltext

Rosuvastatin – A Highly Effective New 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor: Review of Clinical Trial Data at 10–40 mg Doses in Dyslipidemic Patients von Schuster, Herbert

Volltext

PDE3A mutations cause autosomal dominant hypertension with brachydactyly von Maass, Philipp G, Aydin, Atakan, Luft, Friedrich C, Schächterle, Carolin, Weise, Anja, Stricker, Sigmar, Lindschau, Carsten, Vaegler, Martin, Qadri, Fatimunnisa, Toka, Hakan R, Schulz, Herbert, Krawitz, Peter M, Parkhomchuk, Dmitri, Hecht, Jochen, Hollfinger, Irene, Wefeld-Neuenfeld, Yvette, Bartels-Klein, Eireen, Mühl, Astrid, Kann, Martin, Schuster, Herbert, Chitayat, David, Bialer, Martin G, Wienker, Thomas F, Ott, Jürg, Rittscher, Katharina, Liehr, Thomas, Jordan, Jens, Plessis, Ghislaine, Tank, Jens, Mai, Knut, Naraghi, Ramin, Hodge, Russell, Hopp, Maxwell, Hattenbach, Lars O, Busjahn, Andreas, Rauch, Anita, Vandeput, Fabrice, Gong, Maolian, Rüschendorf, Franz, Hübner, Norbert, Haller, Hermann, Mundlos, Stefan, Bilginturan, Nihat, Movsesian, Matthew A, Klussmann, Enno, Toka, Okan, Bähring, Sylvia

Volltext

The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk von Schuster, Herbert

Volltext

Thermoablation: a new treatment option to replace surgical intervention? von Schuster, Herbert, Kopf, Helmut

Volltext

Contrast-enhanced ultrasound: A novel diagnostic approach for the detection of peritoneal dialysis catheter leakages von Ksiazek, Sara H, Schuster, Herbert, Säemann, Marcus D, Vychytil, Andreas, Göndör, Gábor

Volltext

Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12 von Schuster, Herbert, Wienker, Thomas F, Bähring, Sylvia, Bilginturan, Nihat, Toka, Hakan R, Neitzel, Heidemarie, Jeschke, Eva, Toka, Okan, Gilbert, Dennis, Lowe, Adam, Ott, Jürg, Haller, Hermann, Luft, Friedrich C

Volltext

Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families von Pei, Weidong, Baron, Heike, Müller-Myhsok, Bertram, Knoblauch, Hans, Ali Al-Yahyaee, Said, Hui, Rutai, Wu, Xigui, Liu, Lisheng, Busjahn, Andreas, Luft, Friedrich C, Schuster, Herbert

Volltext

ADAM19 cleaves the PTH receptor and associates with brachydactyly type E von Aydin, Atakan, Klenk, Christoph, Nemec, Katarina, Işbilir, Ali, Martin, Lisa M, Zauber, Henrik, Rrustemi, Trendelina, Toka, Hakan R, Schuster, Herbert, Gong, Maolian, Stricker, Sigmar, Bock, Andreas, Bähring, Sylvia, Selbach, Matthias, Lohse, Martin J, Luft, Friedrich C

Volltext

1-Aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors von Coppola, Gary M, Zhang, Y.Larry, Schuster, Herbert F, Russell, Mary E, Hughes, Thomas E

Volltext

Effects of switching to rosuvastatain from atorvastatin or other statins on achievement of international low-density lipoprotein cholesterol goals: MERCURY I trial von Schuster, Herbert

Volltext

Autosomal Dominant Hypertension and Brachydactyly in a Turkish Kindred Resembles Essential Hypertension von Schuster, Herbert, Wienker, Thomas F, Toka, Hakan R, Bahring, Sylvia, Jeschke, Eva, Toka, Okan, Busjahn, Andreas, Hempel, Albrecht, Tahlhammer, Christoph, Oelkers, Wolfgang, Kunze, Jurgen, Bilginturan, Nihat, Haller, Hermann, Luft, Friedrich C

Volltext

Does rosuvastatin improve lipid levels in patients with the metabolic syndrome more effectively than atorvastatin? von Schuster, Herbert

Volltext

Improving lipid management - to titrate, combine or switch von Schuster, H.

Volltext

Risk assessment and strategies to achieve lipid goals: lessons from real-world clinical practice von Schuster, Herbert

Volltext

Case reports illustrate consequences of ATP III in practice von Schuster, Herbert

Volltext

Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol von Knoblauch, Hans, Bauerfeind, Anja, Toliat, Mohammad Reza, Becker, Christian, Luganskaja, Tatjana, Günther, Ulf Peter, Rohde, Klaus, Schuster, Herbert, Junghans, Christine, Luft, Friedrich C., Nürnberg, Peter, Reich, Jens Georg

Volltext